Predicting Risk-Adjusted Incidence Rates of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in the Cystic Fibrosis Programs in the United States
Recommended shielding against COVID-19 impacts physical activity levels in adults with cystic fibrosis
The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and children
Pseudomonas Aeruginosa Antibody Response in Cystic Fibrosis Decreases Rapidly Following Lung Transplantation
